Acquired sensorineural hearing loss occurs as a consequence of damage to the inner ear and may result from tumors, medications, or noise-induced acoustic trauma. Furosemide ototoxicity—manifested by tinnitus, vertigo, or hearing loss—is frequently reversible, but some cases may result in permanent hearing loss.
Purpose
Because of the serious nature of this adverse drug reaction, the intent of this article is heightening the awareness of furosemide-induced ototoxicity through case presentation.
Methods
An updated review of the literature is provided.
Results and Conclusion
The case demonstrates multiple risk factors that can be used to empower readers for identification of patients who are also at high risk. Strategies are presented for avoiding further cases.
RybakL P.Ototoxicity of loop diuretics. Otolarynol Clin North Am.1993; 26(5): 829–844.
2.
FlagellaM., ClarkeL.L., MillerM.L.. Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem.1999; 274(38): 26946–26955.
3.
DelpireE., LuJ., EnglandR., DullC., ThorneT.Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet.1999; 22(2): 192–195.
4.
DingD., McFaddenS.L., WooJ.M., SalviR.J.Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea. Hear Res.2002; 173(1-2): 1–9.
5.
ArnoldW., NadolJ.B.Jr, WeidauerH.Ultrastructural histopathology in a case of human ototoxicity due to loop diuretics. Acta Otolaryngol.1981; 91(5-6): 399–414.
6.
GallagherK.L., JonesJ.K.Furosemide-induced ototoxicity. Ann Intern Med.1979; 91(5): 744–745.
7.
SchwartzG.N., DavidD.S., RiggioR.R., StenzelK.H., RubinA.L.Ototoxicity induced by furosemide. N Engl J Med.1970; 282(25): 1413–1414.
8.
HeidlandA., WigandM.E.The effect of furosemide at high doses on auditory sensitivity in patients with uremia. Klin Wschr.1970; 48: 1052–1056.
BrownC.G., OggC.S., CameronJ.S., BewickM.High dose frusemide in acute reversible intrinsic renal failure. Scott Med J.1974; 19(Suppl 1): 35–39.
11.
RuppW.Pharmacokinetic and pharmacodynamics of Lasix. Scott Med J.1974; 19(Suppl 1): 5–13.
12.
van OldenR.W., van MeyelJ.J., GerlagP.G.Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol.1992; 12(5): 351–356.
13.
GöttlK.H., RoeschA., KlinkeR.Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide, and ozolinone in the cat—a new approach to the problem of ototoxicity. Naunyn Schmiedebergs Arch Pharmacol.1985; 331(2-3): 275–282.
14.
DormansT.P., van MeyelJ.J., GerlagP.G., TanY., RusselF.G., SmitsP.Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol.1996; 28(2): 376–382.
15.
RislerT., SchwabA., KramerB., BraunN., ErleyC.Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure. Cardiology.1994; 84(Suppl 2): 155–161.
BeermannB., DalénE., LindströmB.Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther.1977; 22(1): 70–78.
18.
HoK.M., SheridanD.J.Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ.2006; 333(7565): 420.
19.
ChuP.L., WuC.C., HsuC.J., WangY.T., WuK.D.Potential ototoxicity of aluminum in hemodialysis patients. Laryngoscope.2007; 117(1): 137–141.
20.
VianiA., CarraiM., PacificiG.M.Plasma protein binding of frusemide in liver disease: effect on hypoalbuminaemia and hyperbilirubinaemia. Br J Clin Pharmacol.1989; 28(2): 175–178.
21.
SeligmannH., PodoshinL., Ben-DavidJ., FradisM., GoldsherM.Drug-induced tinnitus and other hearing disorders. Drug Saf.1996; 14(3): 198–212.
22.
LowW.K., TohS.T., WeeJ., Fook-ChongS.M., WangD.Y.Sensorineural hearing loss after radiotherapy and chemotherapy: a single, blinded, randomized study. J Clin Oncol.2006; 24(12): 1904–1909.
23.
JungT.T., RheeC.K., LeeC.S., ParkY.S., ChoiD.C.Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am.1993; 26(5): 791–810.
24.
HoT., VrabecJ.T., BurtonA.W.Hydrocodone use and sensorineural hearing loss. Pain Physician.2007; 10(3): 467–472.
25.
MukherjeeB., ShivakumarT.A case of sensorineural deafness following ingestion of sildenafil. J Laryngol Otol.2007; 121(4): 395–397.
26.
MahasitthiwatV.A woman with sudden bilateral sensorineural hearing loss after treatment of psoriasis with acitretin. J Med Assoc Thai.2005; 88(Suppl 1): S79–S81.
27.
BatesD.E., BeaumontS.J., BaylisB.W.Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother.2002; 36(3): 446–451.
28.
NaranjoC.A., BustoU., SellersE.M.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther.1981; 30(2): 239–245.
